ArticleBone2016

Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model.

Joseph E Perosky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.